CD8A and neoplasm: Interestingly, they reported that, in murine B16F10 melanoma tumor model, ROS complex significantly reduced the expression of matrix metalloprotease2 (MMP2), and both percentage of M2 tumor associated macrophages and Treg into tumor mass, thus increasing and favoring CD8+T lymphocytes.